The pan-inhibitor of VEGF receptors, GW654652 blocks growth and migration of multiple myeloma cells in the bone marrow microenvironment.

被引：0
|
作者：
Podar, K
Tai, YT
Carvalho, P
Catley, LP
Shringarpure, R
Burger, R
Hayashi, T
Pandite, LN
Kumar, R
Pellman, D
Hideshima, T
Chauhan, D
Anderson, KC
机构：
[1] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Univ, Sch Med, Dept Pediat Hematol & Oncol, Dana Farber Canc Inst, Boston, MA USA
[3] Glaxo Inc, Res Triangle Pk, NC 27709 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2563
引用
收藏
页码：692A / 692A
页数：1
相关论文
共 27 条
  • [21] EPO906 (Epothilone B) inhibits cell growth and survival of multiple myeloma cells in the bone marrow microenvironment, in vitro and in vivo.
    Lin, BK
    Catley, LP
    LeBlanc, R
    Gupta, D
    Burger, R
    Tai, YT
    Podar, K
    Wartmann, M
    Griffin, JD
    Anderson, KC
    BLOOD, 2002, 100 (11) : 818A - 818A
  • [22] Targeting Brouton's Tyrosine Kinase with PCI-32765 Blocks Growth and Survival of Multiple Myeloma and Waldenstrom Macroglobulinemia Via Potent Inhibition of Osteoclastogenesis, Cytokines/Chemokine Secretion, and Myeloma Stem-Like Cells in the Bone Marrow Microenvironment
    Tai, Yu-Tzu
    Chang, Betty Y.
    Kong, Sun-Young
    Fulciniti, Mariateresa
    Yang, Guang
    Calle, Yolanda
    Hu, Yiguo
    Lin, Jianhong
    Zhao, Jian-Jun
    Cea, Michele
    Cagnetta, Antonia
    Sellitto, Michael A.
    Chen, Michelle
    Hunter, Zachary
    Carrasco, Ruben
    Buggy, Joseph J.
    Elias, Laurence
    Matsui, William
    Treon, Steven P.
    Richardson, Paul G.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2011, 118 (21) : 404 - 404
  • [23] Targeting Bruton's tyrosine kinase with PCI-32765 blocks growth and survival of multiple myeloma and Waldenstrom macroglobulinemia via potent inhibition of osteoclastogenesis, cytokines/chemokine secretion, and myeloma stem-like cells in the bone marrow microenvironment
    Tai, Yu-Tzu
    Chang, Betty
    Kong, Sun-Young
    Fulciniti, Mariateresa
    Yang, Guang
    Calle, Yolanda
    Hu, Yiguo
    Lin, Jianhong
    Zhao, Jian-Jun
    Cagnetta, Antonia
    Cea, Michele
    Sellitto, Michael
    Chen, Michelle
    Carrasco, Daniel R.
    Elias, Laurence
    Buggy, Joseph
    Treon, Steven P.
    Hunter, Zachary
    Matsui, William
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    CANCER RESEARCH, 2012, 72
  • [24] CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy (vol 113, pg 4341, 2009)
    Azab, Abdel Kareem
    Runnels, Judith M.
    Pitsillides, Costas
    Moreau, Anne-Sophie
    Azab, Feda
    Leleu, Xavier
    Jia, Xiaoying
    Wright, Renee
    Ospina, Beatriz
    Carlson, Alicia L.
    Alt, Clemens
    Burwick, Nicholas
    Roccaro, Aldo M.
    Ngo, Hai T.
    Farag, Mena
    Melhem, Molly R.
    Sacco, Antonio
    Munshi, Nikhil C.
    Hideshima, Teru
    Rollins, Barrett J.
    Anderson, Kenneth C.
    Kung, Andrew L.
    Lin, Charles P.
    Ghobrial, Irene M.
    BLOOD, 2024, 143 (25) : 2673 - 2673
  • [25] B-cell maturation antigen (BCMA) activation in human multiple myeloma cells promotes myeloma cell growth and survival in the bone marrow microenvironment via upregulated MCL-1 and NFκB signaling
    Tai, Yu-Tzu
    Acharya, Chirag
    Zhong, Mike Y.
    Cea, Michele
    Cagnetta, Antonia
    Richardson, Paul
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Constitutive B-Cell Maturation Antigen (BCMA) Activation In Human Multiple Myeloma Cells Promotes Myeloma Cell Growth and Survival In The Bone Marrow Microenvironment Via Upregulated MCL-1 and NFκB Signaling
    Tai, Yu-Tzu
    Acharya, Chirag
    Zhong, Mike Y.
    Cea, Michele
    Cagnetta, Antonia
    Richardson, Paul G.
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    BLOOD, 2013, 122 (21)
  • [27] Targeting CS1, a newly identified human multiple myeloma antigen, by a novel humanized monoclonal antibody HuLuc63, blocks myeloma cell adhesion in the bone marrow microenvironment and induces potent cytotoxicity against myeloma cells even resistant to conventional and novel therapies
    Tai, Y. T.
    Song, W.
    Li, X. F.
    Burger, P.
    Lee, A.
    Leiba, M.
    Podar, K.
    Schlossman, R.
    Rice, A.
    van Abbema, A.
    Richardson, P.
    Munshi, N. C.
    DePinho, R. A.
    Afar, D.
    Anderson, K. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 148 - 148
123